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Abstract 1 
Human parturition is associated with many pro-inflammatory mediators which are 2 
regulated by the Nuclear Factor kappa B (NF-NB) family of transcription factors. In the 3 
present study, we employed a ChIP-on-chip approach to define genomic loci within 4 
chromatin of PHM1-31 myometrial cells that were occupied by RelA-containing NF-NB 5 
dimers in response to a TNF stimulation of one hour. In TNF-stimulated PHM1-31 cells, 6 
anti-RelA serum enriched 13,300 chromatin regions; importantly, 11,110 regions were 7 
also enriched by anti-RelA antibodies in the absence of TNF. DNA sequences in these 8 
regions, from both unstimulated or TNF-stimulated PHM1-31 cultures, were associated 9 
with genic regions including INBD, COX-2, IL6RN, Jun and KCNMB3. TNF-induced 10 
binding events at a consensus NB site numbered 1,667; these were represented by 112 11 
different instances of the consensus NB motif. Of the 1,667 consensus NB motif 12 
occurrences, 770 (46.2%) were identified within intronic regions. In unstimulated PHM1-13 
31 cells, anti-RelA-serum-enriched regions were associated with sequences corresponding 14 
to open reading frames of ion channel subunit genes including CACNB3 and KCNB1. 15 
Moreover, in unstimulated cells, the consensus NB site was identified 2,116 times, being 16 
defined by 103 different sequence instances of this motif. Of these 2,116 consensus NB 17 
motifs, 1,089 (51.5%) were identified within intronic regions. Parallel expression array 18 
analyses in PHM1-31 cultures demonstrated that TNF stimulated a >2-fold induction in 19 
51 genes and a fold repression of >1.5 in 18 others. We identified 14 anti-RelA-serum-20 
enriched genomic regions that correlated with 17 TNF-inducible genes, such as COX2, 21 
Egr-1, Jun, INBD and IL6, as well as five regions associated with TNF-mediated gene 22 
repression, including Col1A2. 23 
Keywords: NF-kappaB / chromatin / labour / microarray / pre-term birth 24 
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Introduction 25 
In the developed world, premature birth (that before 37 weeks completed gestation) 26 
complicates 6-12% of pregnancies (Khashan et al., 2010). Annually it is estimated that 27 
1.1million babies worldwide die from being born prematurely (Blencowe et al., 2012; Chang 28 
et al., 2013); surviving infants having an elevated risk of major long-term mental and physical 29 
handicap (Marlow et al. 2005; Costeloe et al. 2012). Moreover, such infants also have a 30 
disproportionate effect on health-care budgets worldwide: a recent U.K. estimate of the total 31 
cost of preterm birth to the public sector was £2.95 billion (Mangham et al., 2009). Tocolytic 32 
therapies (drugs which stop premature contractions of the womb) are few in number and are 33 
associated with complications for both infant and mother (Oei, 2006). This problem is 34 
compounded by the fact that, despite many years of research, we remain ignorant of the 35 
fundamental biological principles governing uterine function during pregnancy and labour. 36 
 37 
NF-NB Biology and the Myometrium 38 
Regulatory networks between transcription factors and DNA ensure cells function normally. 39 
The Nuclear Factor kappaB (NF-NB) family are one set of transcription factors which govern 40 
a wide variety of cellular activities (reviewed in Perkins, 2007; Perkins, 2012; Hayden and 41 
Ghosh, 2012; Cookson and Chapman, 2010). NF-NB, which is rapidly induced by over 400 42 
different stimuli including TNF (Perkins, 2007; Hayden and Ghosh, 2012; Cookson and 43 
Chapman, 2010), is present in virtually every cell type within the body. NF-NB is composed of 44 
dimeric complexes formed from five distinct subunits: RelA (p65), RelB, c-Rel, NF-NB 1 45 
(p105/p50) and NF-NB 2 (p100/p52) (Perkins, 2007; Perkins, 2012; Hayden and Ghosh, 2012; 46 
Cookson and Chapman, 2010). DNA binding by NF-NB dimers is mediated by a conserved N-47 
terminal domain termed the Rel Homology Region (Chen and Ghosh, 1999). Combinations of 48 
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subunits determine the specificity of transcriptional activation (Perkins et al., 1992; Chen and 49 
Ghosh, 1999); indeed NF-NB can modulate prolonged gene expression through the exchange 50 
of NF-NB dimers at a given promoter (Saccani et al., 2003). 51 
 52 
There are predicted to be in excess of 3,000 NB sites within the human genome with the 53 
consensus NF-N% ELQGLQJ VLWH JHQHUDOO\ YLHZHG DV ¶-G
-5G-4G-3R-2N-1Y0Y+1Y+2C+3C+4-¶54 
(where R = A or G; N = A, C, T or G and Y = C or T; Natoli et al., 2005). Importantly, there 55 
are a great many functional variants of this consensus NB motif and there is now a wealth of 56 
studies describing how NB DNA motifs associate with various NF-NB dimers (Ghosh et al., 57 
1995; Müller et al., 1995; Cramer et al., 1997; Huang et al., 1997; Chen et al., 1998a; Chen et 58 
al., 1998b; Chen and Ghosh, 1999; Phelps et al., 2000; Hoffman et al., 2003; Leung et al., 59 
2004; Huang et al., 2005; Moorthy et al., 2007; Trinh et al., 2008; Wan and Lenardo, 2009; 60 
Wang et al., 2012).  61 
  62 
At term, the smooth muscle of the uterus, the myometrium, is exposed to a complex milieu of 63 
inflammatory signalling factors (Aguilar and Mitchell, 2010; Cookson and Chapman, 2010; 64 
Golightly et al., 2011; Webster et al., 2013). Moreover, there is now a body of evidence that  65 
NF-NB dimers containing the RelA NF-NB subunit play a pivotal role in regulating human 66 
parturition (Belt et al., 1999; Allport et al., 2001; Elliot et al., 2001; Yan et al., 2002a; Yan et 67 
al., 2002b; Lappas et al., 2003; Lee et al., 2003; Chapman et al., 2004; Lappas and Rice, 2004; 68 
Lappas et al., 2004; Soloff, et al., 2004; Chapman et al., 2005; Lindström and Bennett, 2005, 69 
Soloff et al., 2006; Terzidou et al., 2006; Mohan et al., 2007; Lindström et al., 2008).  70 
Consequently, it would seem highly likely that, based on the evidence above, the myometrial 71 
smooth muscle cell could have evolved suitable mechanisms to ensure those NF-NB-regulated 72 
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promoters are expressed only at the correct spatio-temporal juncture. Consistent with this 73 
notion, we have previously demonstrated that temporal changes in NF-NB subunit composition 74 
and associated DNA-binding activity occurs between non-pregnant (NP), pregnant (P) and 75 
spontaneously labouring (SL) myometrium (Chapman et al. 2004). At present, the importance 76 
of this change in NF-NB dimer composition within the uterine smooth muscle is unclear. 77 
Temporal changes in NF-NB subunit composition on NF-NB-regulated promoters, however, 78 
can permit fine-tuning of the transcriptional response ensuring the gene is expressed at the 79 
correct level for the appropriate length of time (Saccani et al., 2003). 80 
 81 
The obvious corollary to those observations, therefore, is that it is highly likely that a similar 82 
temporal manner of regulation is being employed in the uterus ensuring parturition occurs at 83 
the correct juncture. The study described herein examines where NF-NB complexes bind to 84 
chromatin in myometrial cells and whether this binding influenced gene expression in such 85 
cells. Essentially this allows us to determine if NF-NB promoter occupancy is associated with 86 
transcriptional activation, transcriptional repression or homeostasis. 87 
 88 
Materials and Methods 89 
PHM1-31 Cell Passaging 90 
PHM1-31 immortalised human myometrial myocytes were the kind gift of Prof. Barbara 91 
Sanborn, Colorado State University, USA (Monga et al. 1996). Cells were cultured in 92 
'XOEHFFR¶VPRGLILHG(DJOH¶VPHGLXP'0(0VXSSOHPHQWHGZLWKYY)&6DQGP093 
L-glutamine and 0.1 mg/ml Geneticin using published cell culture procedures (Chapman et al. 94 
2005, Webster et al., 2013, Waite et al., 2014).  95 
 96 
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Transient Transfections, Plasmids and Luciferase Assays 97 
Transient transfection of PHM1-31 myometrial cells was performed using the LT-1 reagent 98 
from Miras (Geneflow, Staffordshire UK) as described by Chapman et al., (2005) for primary 99 
myometrial cells. The 3x-NB-ConA-luciferase (3x-NB-ConA-Luc) and enh-ConA-luciferase 100 
('NB-ConA-Luc) vectors were the generous gift of Prof. Ron Hay (University of Dundee, 101 
U.K.) and the construction of these has been reported in detail (Rodriguez et al., 1996). All 102 
transfection experiments were performed a minimum of three times and results are expressed 103 
as the mean ± SEM. All data analyses were conducted on GraphPad Prism Version 5.02 104 
(GraphPad Software, San Diego, California). Comparison of data from two matched samples 105 
were compared using a paired, two-tailed t-test; p<0.05 was considered statistically significant. 106 
 107 
RelA Immunocytochemistry in PHM1-31 Cells Following TNF Stimulation 108 
PHM1-31 cells were cultured in a 24-well plate, washed in PBS and fixed in 1% (v/v) 109 
formaldehyde overnight at 4°C. Endogenous cellular peroxidase was quenched with 1% (v/v) 110 
hydrogen peroxide for 10 minutes. The Vectastain® Elite ABC kit (Vector Labs) was used for 111 
the following reactions. Endogenous biotin was blocked with PBS containing horse serum and 112 
avidin for one hour at room temperature, followed by incubation with primary antibody (anti-113 
RelA, #sc-372, Santa Cruz Biotechnology Inc.) in antibody diluent and biotin at 4°C overnight. 114 
Secondary anti-mouse IgG (Dako) was added for 30 minutes at room temperature before the 115 
addition of the ABC reagent for 30 minutes at room temperature and finally '$%  ¶-116 
diaminobenzidine). Cells were stored in PBS and photographed. Negative control experiments 117 
included the substitution of the primary antibody with an isotype control (Abcam, # ab46450).  118 
 119 
Preparation of Nuclear Extracts and Electrophoretic Mobility Shift Assay (EMSA) 120 
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Nuclear extracts were prepared essentially as described in Dignam et al., (1983). In this study, 121 
the EMSA utilised an oligonucleotide consisting of the HIV-¶ORQJWHUPLQDOUHSHDW/75122 
NB site (in bold; 5¶-GATCCGCTGGGGACTTTCCAGGCG-¶. The EMSA was carried out 123 
as detailed in Chapman et al., (2002 and 2005). 124 
 125 
Western Immunodetection  126 
Expression of the RelA NF-NB subunit was examined using Western analysis with 127 
immunoblots probed with antibodies that recognize either the amino terminal or carboxy 128 
terminal of RelA (p65) (Santa Cruz Biotechnology Inc. Santa Cruz CA #sc-109 and #sc-372 129 
respectively) and developed using EZ-ECL detection reagents (Geneflow, Staffs. U.K.) as 130 
detailed in Chapman et al., (2004). 131 
 132 
Chromatin Immunoprecipitation (ChIP) Assay  133 
The ChIP assay was performed on eight T-75 flasks of PHM1-31 cells (~2.6-2.8x106 134 
cells/flask) grown to 100% confluence using the Magna-ChIP ChIP assay kit (#17-611, 135 
Millipore U.K. Ltd. Dundee) IROORZLQJWKHPDQXIDFWXUHU¶VJXLGHOLQHV and detailed in Webster 136 
et al., (2013). ChIP antibodies used were RelA and RNA Polymerase II (#sc-372 and #sc-899 137 
respectively; Santa Cruz Biotechnology Inc. Santa Cruz CA). Briefly, four flasks were 138 
stimulated with 10ng/ml TNF for one hour while the remaining four were unstimulated 139 
controls. TNF has been demonstrated to be present in myometrium at term (Opsjln et al., 1993; 140 
Fitzgibbon et al. 2009; reviewed in Golightly et al., 2011) and has been used regularly by our 141 
group studying cytokine-induced myometrial NF-NB function (Chapman et al., 2005, Webster 142 
et al., 2013; Waite et al., 2014). The rationale for this time point was that it would represent an 143 
HDUO\UHVSRQVHWR71):HEHOLHYHVXFKHDUO\ELQGLQJHYHQWVSOD\SLYRWDOUROHVLQWKHFHOO¶V144 
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choice of subsequent signalling pathway usage (reviewed in Perkins 2007). It was accepted 145 
that TNF-induced gene regulation events occurring after one hour would not be investigated 146 
(Campbell et al., 2001; Rocha et al., 2003). Three biological replicates of these ChIP assays 147 
were completed. The work-flow utilised to generate the appropriate chromatin samples is 148 
illustrated in Figure 1. 149 
 150 
Quality Control PCR of Immunoprecipitated DNA 151 
Prior to microarray analyses, ChIP efficacy was determined by enrichment of RelA on the 152 
INBD promoter. PCR was carried out on the immunoprecipitated DNA using primers flanking 153 
the NB sites within the INBD promoter as a positive control (Chapman et al. 2005). The GDs 154 
promoter, which is not regulated by RelA was chosen as a negative control (Webster et al., 155 
2013). Once it was determined that the chromatin was of sufficiently high quality, it was then 156 
prepared ready to probe Affymetrix 1.0R Human promoter Arrays (Affymetrix, Santa Clara, 157 
CA).  158 
 159 
Affymetrix Microarrays 160 
Full details of both arrays employed in this study FDQEHIRXQGDWWKHPDQXIDFWXUHU¶VZHEVLWH:  161 
GeneChip Human Promoter 1.0R Array:  162 
http://www.affymetrix.com/estore/catalog/131461/AFFY/Human+Promoter+1.0R+Array#1_163 
1  164 
Human Genome U133 Plus 2.0 Array: 165 
http://www.affymetrix.com/catalog/131455/AFFY/Human+Genome+U133+Plus+2.0+Array166 
#1_1 167 
 168 
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ChIP DNA Amplification, Fragmentation and Labelling 169 
ChIP DNA was amplified using the Whole Genome Amplification Kit (WGA; Sigma) as 170 
detailed in tKHPDQXIDFWXUHU¶VLQVWUXFWLRQVwith slight modifications. Briefly, 1 Pl of ChIP DNA 171 
was diluted with 9 µl of ultrapure water. Then 2 µl  of library preparation buffer together with 172 
1 µl of library stabilisation solution was added to this and heated at 95ºC for 2 minutes before 173 
cooling on ice. After that, 1 µl of library preparation enzyme was added and the reaction was 174 
incubated in the thermal cycler for the following times: 20 minutes at 16ºC (pre-cooled to this 175 
temperature), 20 minutes at 20ºC, 20 minutes at 37ºC, 5 minutes at 75ºC, and on hold at 4ºC. 176 
The amplified DNA was re-amplified using the WGA re-amplification kit to generate the 7.5 177 
µg required.  This method is described in the PDQXIDFWXUHU¶V guidelines (Sigma). The re-178 
amplified DNA was then fragmented and labelled according to the Affymetrix ChIP Protocol 179 
using the GeneChip WT Double-Stranded DNA Terminal Labelling Kit. 180 
 181 
Human Promoter 1.0R Array Procedures 182 
Hybridisation of amplified DNA to Affymetrix Human Promoter 1.0R arrays was carried out 183 
using the GeneChip Hybridization, Wash and Stain kit (Affymetrix) according to the 184 
Affymetrix ChIP Protocol. The hybridisation cocktail (7.5 µg fragmented labelled DNA, 50pM 185 
control oligonucleotide B2, hybridisation mix, 7% (v/v) DMSO) was hybridised in the 186 
Affymetrix GeneChip Hybridisation Oven 640. Washing and staining was carried out using 187 
the GeneChip Fluidics Station 450 as described in the GeneChip Expression Wash, Stain and 188 
Scan User manual (Affymetrix). The GeneChip Scanner 3000 7G, operated by the GeneChip 189 
Opertating Software (GCOS, Affymetrix), was used to scan the Human Promoter 1.0R Arrays. 190 
  191 
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Data Analysis in Partek Genomics Suite 6.6 192 
The raw data (.CEL) files, generated by the GCOS software, were imported into Partek 193 
Genomics Suite (PGS; Version 6.6; www.partek.com/pgs) and subjected to Robust Multi-array 194 
Average (RMA) background correction, quantile normalisation and Log (base2) transformation 195 
XWLOLVLQJ WKH VRIWZDUH¶V WLOLQJ ZRUNIORZ Prior to invoking an ANOVA, the data were 196 
normalised to the baseline by subtraction of all values ascribed to IgG samples from both 197 
unstimulated controls and TNF-treated samples since these values would represent non-198 
specific binding events (Fig.1; illustration of work-flow). A two-way ANOVA was then 199 
completed within PGS to undertake multiple comparisons and determine the difference 200 
between unstimulated controls and TNF-treated samples at probe-level. Differences between 201 
control and TNF-stimulated samples were considered significant if pİ0.05. 202 
 203 
Upon completion of the ANOVA, the Model-based Analysis of Tiling (MAT) algorithm (T 204 
statistic) was employed to detect enriched regions of chromatin in un-stimulated and TNF-205 
stimulated data sets (Johnson et al. 2006). The MAT algorithm allows a rapid method of 206 
detecting regions enriched by a given transcription factor (in this study RelA-containing NF-207 
NB dimers). The MAT algorithm was then applied across a sliding window of 600bp, using a 208 
minimum of 10 probes per region with ChIP-enriched regions deemed to be statistically 209 
significant when pİ0.01: this output was the MAT score. Those regions with a positive MAT 210 
score and p value İ 0.05 from the ANOVA indicated significant enrichment by anti-RelA 211 
antiserum in those samples treated with TNF compared to untreated controls. Conversely, a 212 
negative MAT score and p value İ 0.05 from the ANOVA represented those samples where 213 
enrichment of genomic loci was greater in unstimulated controls compared to those exposed to 214 
TNF. Promoters of known genes within the significantly enriched regions were then identified 215 
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using the RefSeq database, based on the hg18 build of the human genome. All of the array data 216 
has been archived with the NCBI Gene Expression Omnibus (NCBI GEO) with the accession 217 
number GSE65721 (www.ncbi.nlm.nih.gov/geo); this number covers all associated 218 
experimental sub-series. All tables of original data sets can be accessed and down-loaded from 219 
the folder entitled Cookson et al 2015 Public Access MHR Original Data Sets at the following 220 
hyperlink:  221 
https://drive.google.com/folderview?id=0B4bwcdSzbmn8OXdLWEtKemxtb0k&usp=sharing 222 
 223 
RNA Extraction 224 
On reaching 90% confluence, PHM1-31 cells were stimulated with 10ng/ml TNF for one hour 225 
with non-stimulated flasks serving as controls. RNA was extracted using the EZ-RNA 226 
extraction system (Geneflow, Staffs. U.K.) and quantified using the nanophotometer (Implen; 227 
supplied by Geneflow, Staffs. U.K.). Prior to first strand synthesis, the quality of isolated RNA 228 
ZDVYHULILHGXVLQJ$JLOHQW¶V(XNDU\RWH7RWDO51$1DQR&KLS-1511) in conjunction with 229 
the Agilent 2100 bioanalyser IROORZLQJ WKH PDQXIDFWXUHU¶V JXLGHOLQHV. Three biological 230 
replicates were performed.  231 
Affymetrix U133plus2 Human Expression Array Procedures 232 
RNA was reverse transcribed using Bio-Rad iScript cDNA synthesis Kit according to the 233 
PDQXIDFWXUHU¶V JXLGHOLQHV %LR-Rad Laboratories Ltd. Hertfordshire U.K.). The preparation 234 
and hybridisation of cDNA to U133Plus2 expression arrays was performed according to 235 
published protocols (Kirby et al. 2011; Simpson et al., 2011; Brockington et al., 2013; Raman 236 
et al., 2015). 237 
 238 
Data Analysis in Partek Genomics Suite 6.6 239 
Page 12 of 51 
 
Page 12 of 51 
 
The raw data files (.CEL) were imported into PGS V6.6 and analysed following the VRIWZDUH¶V 240 
Gene Expression workflow. Differentially expressed genes were identified using ANOVA to 241 
generate p values. Linear contrast was used to calculate fold-change and mean ratio from the 242 
FRQWUDVWEHWZHHQXQVWLPXODWHGDQG71)VWLPXODWHGVDPSOHV*HQHVZLWKIROGFKDQJHRU243 
IROGFKDQJH-DQGZLWKSYDOXHVZHUHLGHQWLILHGXVLQJ5HI6HT 244 
 245 
Data Analysis of Combined Human Promoter 1.0R and U133plus2 Human Expression 246 
Arrays 247 
Using PGS, the enriched region list from both Criteria-A and Criteria-C were merged with the 248 
respective gene list from the expression array analyses. This provided data defining NF-NB-249 
enriched regions that were either expressed or repressed. 250 
 251 
Validation of Microarray Results by qRT-PCR 252 
Quantitative RT-PCR using SYBR Green Jumpstart Taq ReadyMix (Sigma, UK) was 253 
undertaken following MIQE guidelines (Bustin et al. 2009). *$3'+ DQG ȕ-Actin were 254 
selected as housekeeping genes. The primer sequences were as follows:  255 
71)$,3)RUZDUG¶-TGAGCCCTTGGCGTGGAACC-¶ 256 
71)$,35HYHUVH¶-AAAGGGCTGGGTGCTGTCGG-¶ 257 
NFKBIA )RUZDUG¶- CGCCCAAGCACCCGGATACA-¶ 258 
1).%,$5HYHUVH¶- GGGCAGCTCGTCCTCTGTGA-¶ 259 
*$3'+)RUZDUG¶-TGTTCGACAGTCAGCCGCATCT-¶ 260 
*$3'+5HYHUVH¶-CAGGCGCCCAATACGACCAAATC-¶ 261 
E-$FWLQ)RUZDUG¶-CGAGCACAGAGCCTCGCCTT-¶ 262 
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E-$FWLQ5HYHUVH¶- CGAGCACAGAGCCTCGCCTT -¶.  263 
qPCR was performed in triplicate using a 7900HT fast qPCR Machine (Applied Biosystems) 264 
and gene expression data were analysed using ǻǻ&7 using SDS 2.0 Software (Applied 265 
Biosystems). 266 
 267 
Results  268 
TNF induces RelA Nuclear Localisation and Occupancy of the INBD Promoter in PHM1-269 
31 Cells 270 
A number of pro-inflammatory cytokines, including TNF, are associated with the onset of both 271 
normal and preterm birth (Aguilar and Mitchell, 2010; Golightly et al., 2011). Prior to the 272 
ChIP-on-chip experiments, it was important to confirm that in PHM1-31 cells, NF-ț%5HO$273 
was activated by stimulation with TNF. RelA immunocytochemistry of PHM1-31 cells showed 274 
diffuse staining in the control, unstimulated cells and those stained with control IgG, (Fig. 2A; 275 
Panels I and II) whilst translocation of the RelA subunit into the nucleus (black arrows) was 276 
apparent following 1 hour TNF stimulation (Fig. 2A; Panel III). Moreover, increased RelA 277 
binding to the consensus NB site in EMSA was also seen and that binding activity could be 278 
specifically super-shifted with anti-RelA antiserum (Fig. 2B). Furthermore, when PHM1-31 279 
cells were transiently transfected with the RelA-responsive 3x-NB-luc reporter and 280 
subsequently exposed to TNF for one hour, increased reporter activity was seen in those cells 281 
harbouring the 3x-NB-luc vector, but not those with the 'NB-luc control (Fig. 2C). 282 
 283 
Immunoprecipitation using the RelA antiserum (sc-372) showed specific binding to the RelA 284 
protein, while the control IgG failed to precipitate any RelA complexes (Fig. 2D). To 285 
demonstrate the specificity of the ChIP, the RelA antiserum detected low level binding of RelA 286 
Page 14 of 51 
 
Page 14 of 51 
 
complexes to the ,ț%Įpromoter region without TNF stimulation; as predicted, this increased 287 
upon TNF exposure. No binding was seen at the RelA-insensitive GDs promoter. Supporting 288 
this, after exposure to TNF, RNA PolII binding was also observed at the ,ț%Įpromoter. These 289 
results illustrate that the immunoprecipitation and ChIP methods were specific for the RelA 290 
NF-NB subunit. Interestingly, while we see a low-level of NF-NB occupancy of the INBD 291 
promoter under unstimulated conditions, we could not detect a similar pattern of 292 
immunostaining (Fig. 2A, Panels I and II). 293 
 294 
TNF Induces RelA NF-NB Promoter Occupancy at a Variety of Promoters 295 
In this study of PHM1-31 myometrial myocytes, statistically significant differences in 296 
promoter occupancy between unstimulated and TNF-treated cultures were observed in 24,410 297 
genomic regions enriched by the anti-RelA antiserum S WKHVH GDWD ZHUH WHUPHG298 
Criteria-B and represent all enriched regions from both unstimulated and TNF-treated cultures 299 
(Fig. 3A; Original Data Set - Table 1). Within the set Criteria-B, defining the MAT algorithm 300 
parameters to enriched values of >0 and p0.01 (i.e. a positive MAT score) generated 13,300 301 
genomic loci that were significantly more enriched by the anti-RelA antiserum in TNF-treated 302 
cells compared to unstimulated controls; this subset was termed Criteria-A (Fig. 3A; Original 303 
Data Set - Table 2) and represents TNF-induced enrichment.  304 
 305 
Similarly within the Criteria-B dataset, defining the MAT algorithm parameters to enriched 306 
values of <0 and p0.01 (i.e. a negative MAT score), we identified 11,110 genomic regions 307 
that were significantly more enriched by the anti-RelA antiserum in the unstimulated control 308 
set compared to the TNF-treated samples. This subset was termed Criteria-C and represents 309 
unstimulated enrichment. Therefore, in this study, the Criteria-C dataset identifies genomic 310 
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loci bound by NF-NB dimers containing the RelA subunit (homo- or heterodimers of RelA) 311 
when the cell population is not exposed to an exogenous stimulant such as TNF (Fig. 3A; 312 
Original Data Set - Table 3). While we cannot rule out the possibility that some RelA-enriched 313 
regions may be non-specific, the removal of the IgG-associated regions will minimise such 314 
interference. 315 
 316 
RelA-enriched loci from both Criteria-A and Criteria-C datasets represent given regions of 317 
chromatin and thus may map to different aspects of a gene including exons and introns. Fig. 318 
3B illustrates a schematic representation of chromosome 14 (the INBDlocus) illustrating such 319 
differentially enriched regions listed in either Criteria-A (TNF-induced; red vertical lines) or 320 
Criteria-C (unstimulated; blue vertical lines) datasets.  321 
 322 
RelA-Enriched Regions Encoding or Juxtaposed to Genes Associated with Parturition 323 
Enrichment of chromatin from TNF-treated cells by anti-RelA serum was seen to contain or be 324 
juxtaposed to regions encoding many genes believed to play a significant role in myometrial 325 
quiescence or labour itself including, but not limited to, PTGS2, Jun, IL6RN, IL6, CACNB3, 326 
KCNMB3, TRPC2 and VCAM-1 (Original Data Set - Table 4; Criteria-A and Original Data 327 
Set - Table 5; Criteria-C). Figure 4 illustrates examples of genes identified in RelA-enriched 328 
chromatin after cells were stimulated with TNF. Of these, regions harbouring PTGS2 and Jun 329 
were enriched in the presence of TNF (Figs. 4A-4B; Criteria-A regions are red bars) and those 330 
regions also encoded NB motif(s) that were in agreement with the published NB consensus site. 331 
For PTGS2 a region was also enriched in the absence of TNF but no consensus NB motif was 332 
identified therein. Interestingly, genes encoding IL6RN and KCNMB3 were also enriched in 333 
the presence of TNF but no discernible consensus NB motif could be identified in those 334 
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respective Criteria-A enriched regions, suggesting a non-consensus NB motif was being 335 
utilised (Figs. 4C-4D; red bars). Moreover, we also observed that intronic regions of both 336 
IL6RN and KCNMB3 were also enriched by RelA NF-NB in the absence of TNF stimulation 337 
suggesting that RelA-containing dimers do have a function in governing expression of these 338 
genes (Figs. 4C-4D; blue bars). Finally, regions that were only enriched by RelA-containing 339 
dimers in the absence of TNF (i.e. unstimulated) were also examined. Examples of such regions 340 
were those encoding regulatory subunits of calcium and potassium channels such as CACNB3 341 
and KCNB1 (Figs. 4E-4F; blue bars). Significantly, regions encoding these ion channel 342 
subunits also harboured NB motifs corresponding to the consensus NB sequence (Figs. 4E-4F).  343 
 344 
To ensure our experimental system was functioning correctly, we also examined the NF-NB-345 
regulated the INBD promoter region (LeBail et al., 1993). As expected, in TNF-treated cells, 346 
aspects of the INBD promoter were enriched by anti-RelA serum. Interestingly, however, no 347 
enrichment of the INBD promoter was observed in the absence of TNF (Fig. 5A) despite this 348 
region being weakly amplified in the control ChIP assay (Fig. 2E). Increasing the resolution of 349 
the schematic representation in Fig. 5A illustrates two regions within the INBD gene enriched 350 
in TNF-treated cells (Fig. 5B). The region upstream of the INBD transcription start site was 351 
also seen to encode the three NB motifs believed to be responsible for governing INBD 352 
expression (LeBail et al., 1993). A second intra-genic region within INBD open reading frame 353 
was seen to be enriched in TNF-treated cells although no consensus NB motifs were identified 354 
therein (Fig. 5B). In contrast to genes in close proximity to the anti-RelA serum enriched loci, 355 
other enriched regions were decidedly more remote from the nearest genes (Original Data Set 356 
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- Table 4, Criteria-A and Original Data Set - Table 5, Criteria-C; full annotated gene lists 357 
associated with these enriched regions can also be viewed therein).  358 
 359 
Frequency of NB site Motif Occurrence in Criteria-A and Criteria-C Datasets 360 
In the Criteria-A dataset (i.e. RelA-enriched regions in response to TNF), 1,667 occurrences 361 
of the ț% consensus sequence were identified, defined by 112 different sequence 362 
representations (Original Data Set - Table 6). Of the 1,667 occurrences, 1,604 resided in non-363 
repetitive genomic regions. To aid clarity, we focussed the study on those motifs from the non-364 
repetitive regions. These motifs were defined by 65 different sequence instances (Table 1). The 365 
remaining 63 occurrences, whilst not studied further, were defined by 47 different sequence 366 
instances many of which were also observed in the non-repetitive dataset (data not shown). Of 367 
the 1,667 consensus NB motif occurrences in the Criteria-A dataset, 770 (46.2%) were 368 
identified within intronic regions (Original Data Set - Table 6). 369 
 370 
In the Criteria-C data set (i.e. RelA-enriched regions in absence of TNF), the consensus NB 371 
motif occurred 2,116 times defined by 103 different sequence representations (Original Data 372 
Set - Table 7). Of the 2,116 occurrences, 2,064 were seen to reside in non-repetitive elements 373 
of the genome. These were chosen for further study. In turn, these motifs were also represented 374 
by 65 different sequence instances (Table 1). The remaining 52 occurrences, whilst not studied 375 
further as they were from highly repetitive sequences, were defined by 38 different sequence 376 
instances many of which were also observed in the non-repetitive dataset (data not shown). Of 377 
the 2,116 consensus NB motif occurrences in the Criteria-C dataset, 1,089 (51.5%) were 378 
identified within intronic regions (Original Data Set - Table 7). 379 
 380 
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Overall, the consensus NB motif was observed a total of 3,783 times in anti-RelA serum-381 
enriched genomic regions with 3,720 NB motifs identified in non-repetitive elements of the 382 
genome of PHM1-31 myometrial myocytes. Alignment of the 65 representations of the ț% 383 
sequence was performed using WebLogo 3 open access software (Crooks et al. 2004; 384 
http://weblogo.threeplusone.com/). Consensus NB sequence variability was seen to be 385 
¶***$*$&7*&7&7&7&&-¶ EXW QR GLIIHUHQFH ZDV observed with this 386 
between Criteria-A (TNF-induced enrichment) and Criteria-C (un-stimulated enrichment) 387 
(Fig. 6).   388 
 389 
Expression Array Analysis of PHM1-31 Gene Expression Induced by TNF 390 
As illustrated thus far, promoter occupancy by RelA-containing NF-NB dimers per se, does not 391 
provide information on associated transcriptional levels (i.e. expressed, repressed or quiescent; 392 
akin to chromatin-bound RNA polymerase II and promoter-proximal stalling (Core and Lis, 393 
2009)). Consequently, we undertook expression array analyses in PHM1-31 cells utilising total 394 
RNA extracted from cells exposed to TNF for one hour (an identical time course to those used 395 
to isolated chromatin for ChIP-on-chip studies). 396 
 397 
A statistically significant change in expression of 2,963 genes was induced by TNF 398 
(Supplementary Information - Data Table 8 p-value region<0.05). Expression of six genes 399 
remained unchanged between unstimulated and TNF-treated cells (SLC35F5, DEFB106A, 400 
RFTN1, DTWD2, SLC34A3 and SEZ6L). Removal of duplicates from the original data gave 401 
a total of 2,223 genes that were differentially expressed when PHM1-31 cells were stimulated 402 
with TNF for one hour (Fig. 7; Criteria-B1, p<0.05; and Original Data Set - Table 8). Of this 403 
total, 51 genes were seen to have a fold-induction of  >2. Of these, two were discounted as they 404 
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were not annotated, leaving a total of 49 genes; these were termed Criteria-A1. Physiologically 405 
relevant genes identified in this dataset were EGR 1-4, FOS, FOSB, JUN, JUNB, ATF3, 406 
NFKIBIA, NFKBIZ, TNFAIP3, COX2, CXCL2, CXCL3, CCL20, LIF, IL-6, MAP3K8, 407 
THBS1 and TNF. Eighteen genes were seen to have a fold repression of  >1.5. Of these, one 408 
was not annotated and was thus excluded leaving a total of 17 genes; these were termed 409 
Criteria-C1 (Fig. 7). Included in this dataset were HOXA11, COL1A2 and STAT2. To 410 
summarise, Table II lists those genes whose expression was induced by at least two-fold in 411 
response to TNF while Table III lists those genes subject to repression by at least 1.5 fold in 412 
the presence of TNF. Further details from the expression array analyses can be viewed in 413 
(Original Data Set - Tables 8-10). 414 
 415 
Combined Analysis of PHM1-31 Promoter Occupancy and Gene Expression 416 
Merging the Criteria-A TNF-enriched promoter dataset with Criteria-A1 (TNF-induced gene 417 
expression), 14 TNF-induced, RelA-enriched genomic regions from the promoter array screen 418 
also encoded TNF-inducible genes (Table II; genes annotated with * and Supplementary 419 
Information - Data Table 11). These included known NF-ț%-regulated genes IL-6, Jun, 420 
NFKBIA, PTGS2, TNC and TNFAIP3. Genes not yet conclusively demonstrated to be under 421 
NF-ț% control included DUSP-2, DUSP-5, ERRFI1, THBS1 and CTGF (Table II; genes 422 
annotated with * and Original Data Set - Table 11). Moreover, by combining the Criteria-A 423 
promoter array dataset with the expression array Criteria-C1 dataset (TNF-repressed genes), 424 
we also identified five RelA-enriched genomic regions that harboured TNF-repressed genes, 425 
including COL1A2 (Table III; genes annotated with * and Original Data Set - Table 12).  426 
 427 
Gene Ontology and Validation of Selected RelA-enriched Regions Modulated by TNF 428 
Page 20 of 51 
 
Page 20 of 51 
 
PGS Gene Ontology analysis identified two functional groups of interest in the Biological 429 
Processes category: Intra-cellular Signal Transduction and Cell Surface Receptor Protein 430 
Signalling. These included TNFAIP3 (Cytokine-Induced Signalling) and INBD (NIK/NF-NB 431 
Signalling; Fig. 8A). These targets were subsequently used to validate the expression array data 432 
because both have important roles in governing TNF signalling and NF-NB function 433 
respectively (Perkins, 2007; Chen and Ghosh, 1999; Hayden and Ghosh, 2012). Real-time 434 
qRT-PCR on total RNA from PHM1-31 cells treated with TNF for one hour demonstrated that 435 
both INBD and TNFAIP3 were expressed in response to TNF. Good agreement was observed 436 
for induction of gene expression for INBD (Fig. 8B; 2.94 on array vs. 4.43 for qRT-PCR) while 437 
a slightly greater margin of difference was noted for TNFAIP3 expression (Fig. 6B; 7.96 on 438 
array vs. 3.85 for qRT-PCR). 439 
 440 
Discussion 441 
NF-NB Binding and Distribution in the Genome of TNF-stimulated and Unstimulated Cells  442 
This report is the first to describe a promoter array-based approach to define chromatin regions 443 
of myometrial myocytes occupied by RelA-containing NF-NB dimers. Our data demonstrated 444 
that in PHM1-31 myometrial cells, NF-NB-mediated enrichment of 13,300 chromatin regions 445 
in the presence of TNF and 11,110 in unstimulated cells. Some of these regions were 446 
juxtaposed to genes known to function in human labour, for example PTGST2 (Chan et al., 447 
2014) and KCNMB3. NF-NB-controlled regulation of PTGS2 in the myometrium and amnion 448 
is well documented (Allport et al., 2001; Soloff et al., 2004; Lindström and Bennett, 2005) 449 
while a putative role in governing gene activity of the potassium channel subunit KCNMB3 is 450 
less so. In contrast, other RelA-enriched regions were decidedly more remote from the nearest 451 
transcription start with distances being measured in numbers of kilobases. Many of these loci 452 
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were also noted to be within intronic regions as discussed below. We did not examine the 453 
influence of such remote binding events in this study but we cannot rule out that they represent 454 
enhancer sequences or non-coding RNA transcriptional units. Indeed, supporting this notion 455 
are the observations that many transcription factor binding sites are arranged many kilobases 456 
from the transcription start site of the genes they regulate (Deaton and Bird, 2011). 457 
 458 
NB Binding Site Loci  459 
Intriguingly, RelA appeared to exhibit stimulus dependent binding to different loci of the same 460 
gene; this was evidenced with PTGS2, IL6RN and KCNMB3. In contrast, however, a section 461 
of the promoter region for Jun was only enriched in the presence of TNF while for CACNB3 462 
and KCNB1, sections of promoter regions for these respective genes were only enriched by 463 
RelA-containing dimers in the absence of TNF; the molecular mechanisms accounting for these 464 
observations remain to be established. We did, however, determine that in both datasets, the 465 
consensus NB motif was represented a total of 3,783 times, including 1,859 (49.14%) sites 466 
identified within intronic regions. A number of studies in various cell lines have reported such 467 
intronic binding by NF-NB (Martone et al., 2003; Schreiber et al., 2006; Lim et al., 2007; Wong 468 
et al., 2011; Satohn, 2013; Xing et al., 2013) and, given that the early work describing its 469 
function demonstrated it was bound to the first intron of the N-light chain enhancer (Schjerven 470 
et al., 2001), our observations support such previous data. Interestingly there are reports of 471 
transFULSWLRQRIFHUWDLQUHJXODWRU\SURWHLQVLQLWLDWLQJIURPZLWKLQWKH¶-intronic regions of the 472 
parental gene. The calcium channel associated transcriptional regulator (CCAT), for example, 473 
is generated through initiation of independent transcription of exons DQGDWD¶-intronic 474 
site of the parental Cav1.2 calcium channel gene (Gomez-Ospina et al., 2013). Clearly, our data 475 
does not illustrate if such NF-NB binding directly modifies gene activity in this manner but it 476 
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offers a likely rationale for such intronic binding, perhaps as a means of governing post-477 
transcriptional RNA splicing, and a further avenue for investigating the complexities of 478 
myometrial gene activity as labour commences. Due to the apparent promiscuity of RelA 479 
binding to multiple loci and limited sensitivity of the ChIP-on-chip methodology, ChIP-exo 480 
(see below) would be a superior means by which to narrow down the precise binding location 481 
of RelA-containing dimers to near single base pair resolution (Rhee and Pugh, 2012).  482 
 483 
Selection of NB Motifs  484 
The consensus N% ELQGLQJ PRWLI LV YLHZHG DV ¶-G
-5G-4G-3R-2N-1Y0Y+1Y+2C+3C+4-¶ ZLWK485 
many functional variants on this being reported (Perkins, 2007; Hayden and Ghosh, 2012; Chen 486 
and Ghosh, 1999). This motif does offer a level of subunit selectivity and crystallographic 487 
studies of various NF-NB dimers bound to different NB DNA sequences support this (Ghosh et 488 
al., 1995; Müller et al., 1995; Cramer et al., 1997; Huang et al., 1997; Chen et al., 1998a; Chen 489 
et al., 1998b; Phelps et al., 2000; Huang et al., 2005; Moorthy et al., 2007; Trinh et al., 2008). 490 
The actual NB DNA sequence clearly does impose binding constraints upon certain dimers; for 491 
example, within the NB motif, the ¶-G
-5G-4G-3R-2N-1-¶KDOIVLWHLVERXQGE\SLQFRQWUDVW492 
WKH ¶-Y+1Y+2C+3C+4-¶ KDOI VLWH LV QHFHVVDU\ IRU 5HO$ ELQGLQJ (Huang et al., 2005 and 493 
references therein). Whether region-enrichment is dimer-specific and dependent on the nature 494 
of the stimulus (in this case TNF or not) could not be determined herein. Since we focussed on 495 
immunoprecipitated RelA, this would recover four possible groups of RelA-containing dimers; 496 
RelA:RelA, RelA:c-Rel RelA:p50 and RelA:p52 (RelA:RelB heterodimers are not thought to 497 
bind DNA; Marienfeld et al., 2003). Given the published physical constraints imposed upon 498 
certain NF-NB dimer:NB motif interactions (Phelps et al., 2000; Huang et al., 2005) one could 499 
propose that, at this time-point of one hour, it is likely the RelA:p50 or RelA:p52 heterodimers 500 
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are being physiologically favoured. Given that we focussed on RelA, the obvious confounder 501 
of our work is that those enriched regions would likely reflect only contributions from such 502 
RelA-containing dimers; other non-RelA dimers would be missed. As above, further studies 503 
employing ChIP-seq would be required to provide the higher resolution data defining whether 504 
dimer composition on individual promoters/loci changed over multiple time points.  505 
 506 
Limitations of ChIP-on-chip  507 
While ChIP-on-chip is a robust, well-documented method to analyse transcription factor-508 
mediated chromatin enrichment on a whole genome scale, it is associated with limitations when 509 
compared with more recent sequencing technologies including ChIP-seq (reviewed in Hurd 510 
and Nelson, 2009; Park, 2009). The obvious corollary, therefore, is that we cannot rule out the 511 
possibility that bias occurred in our system and influenced the data presented herein. A 512 
comparison between both ChIP-on-chip and ChIP-seq methodologies has been highlighted in 513 
Ho et al. (2011) who address the limitation and benefits associated with both technologies. 514 
With whole genome sequencing now available in most institutions, and methods including 515 
ChIP-exo (essentially ChIP-seq but using lambda exonuclease to trim the immunoprecipitated 516 
DNA to within a few base pairs of the binding residues on a given transcription factor) being 517 
developed, the next step would be to conduct ChIP-seq with all NF-ț% subunit antisera, at 518 
different time points to obtain an unbiased genome-wide signature of binding events taking 519 
place within myometrial cells.  520 
 521 
In our study, we employed the GeneChip 1.0R Human Promoter array. This contains 25,500 522 
human promoter regions but it lacks full genomic coverage of the corresponding tiling arrays. 523 
Consequently, we cannot rule out the possibility that the low correlation between region 524 
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enrichment and subsequent transcription expression/repression could arise because the Human 525 
1.0R Promoter array was not fully representative of the complete human genome.  526 
 527 
PHM1-31 cultures were not cell-cycle synchronised prior to the ChIP assay because the 528 
induction of synchronisation itself (serum starvation) has been documented to effect expression 529 
of key genes involved in cell function and ion transport including the MaxiK potassium channel 530 
as well both the L- and T-type calcium channels (Woodfork et al., 1995; Panner et al., 2005; 531 
Patel et al., 2005). Essentially, potassium channels are responsible for hyperpolarising the 532 
plasma membrane, an event necessary for the cells to move from G1 to S (Wonderlin and 533 
Strobl, 1996; Ouadid-Ahidouch and Ahidouch, 2013). Calcium channels are thought to provide 534 
transient signals at checkpoints within the cell cycle which are necessary for the cell to continue 535 
cycling (Whitaker, 2006). We believe it highly likely that these events would have influenced 536 
those TNF-induced effects reported herein (Perkins, 2012). 537 
 538 
Promoter Occupancy and Transcriptional Activity  539 
Occupancy of a given promoter by NF-NB does not necessarily mean transcriptional activity 540 
directed by that promoter will change and there is robust data to support this notion (Hoffman 541 
et al., 2003; Leung et al., 2004; Wan and Lenardo, 2009; Wang et al., 2012). Of the TNF-542 
induced NF-NB-enriched regions identified in our work, 14 were correlated with an increase in 543 
gene expression while five targets were repressed. Therefore, one must ask why the disparity 544 
between the number of enriched regions and the number of genes with altered activity? Clearly 545 
under normal physiological conditions, the myometrium would be bathed in a milieu rich in 546 
cytokines including IL-1E, IL-6, IL-8 and TNF to name but a few (Aguilar and Mitchell, 2010; 547 
Golightly et al., 2011; Webster et al., 2013). The manner by which these other proinflammatory 548 
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stimulants influence NF-NB activity was not examined herein but it is reasonable, based on 549 
published evidence, to assume these factors would also moderate myometrial gene activity. 550 
Secondly, it is without doubt that we will have missed many key binding events at promoters 551 
at immediate early time points, ranging from seconds to minutes, as well as more prolonged 552 
stimuli after a number of hours. Indeed, this approach may underlie why we did not observe 553 
enrichment of regions that encoded genes for IL-1E, oxytocin or oxytocin receptor, all of which 554 
have previously been shown to require NF-NB for induction of expression (Belt et al., 1999; 555 
Lee et al., 2003; Soloff et al., 2006; Terzidou et al., 2006). 556 
 557 
Differential Gene Expression  558 
In the context of premature birth research, many authors have published expression array 559 
studies in attempts to define genes responsible for promoting myometrial quiescence and 560 
myometrial contraction. Such studies have focussed on native tissues (amnion, decidua and 561 
myometrium) as well as both immortalised and primary cell lines (Charpigny et al., 2003; 562 
Bethin et al., 2003; Bailey and Europe-Finner, 2005; Bailey et al., 2005; Esplin et al., 2005; 563 
Havelock et al., 2005; Han et al., 2008; Khanjani et al., 2011; Lim et al., 2012).  564 
 565 
A recent study by Chan et al. (Chan et al., 2014), used a robust RNA-seq-based approached to 566 
define 764 differentially expressed genes in human myometrium from pregnant, non-labouring 567 
women and those women in active labour. Salient examples of up-regulated genes from that 568 
list included IL6, IL8, IL13, MCP, enzymes governing prostaglandin biosynthesis (PTGS2), 569 
THBS2, DUSP family members, members of the NF-NB family of proteins, and intermediates 570 
in the TGF-E and TNF-signalling pathway (Chan et al., 2014). Significantly, our study of TNF-571 
stimulated differential gene expression identified 49 induced genes; of these expressed genes, 572 
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17 were also represented in the list of genes up-regulated in labouring human myometrium 573 
documented by Chan et al. (Chan et al., 2014). Furthermore, 14 of the TNF-induced genes 574 
were also seen to be in regions of chromatin enriched by RelA. This is a key observation 575 
because it indirectly validates our own expression array work. Moreover, it supports the notion 576 
that NF-NB plays a pivotal role in controlling expression of genes involved in human 577 
parturition since many of those targets identified by Chan et al. are documented to be regulated 578 
by NF-NB (www.bu.edu/nf-kb/gene-resources/target-genes/). 579 
 580 
Interestingly, a recent meta-analysis of gestational tissue-based transcriptomic studies 581 
highlighted significant variation in expression of individual genetic regions; essentially only 582 
23 common sites were identified out of 10,993 unique transcriptionally active units (Eidem et 583 
al., 2015). Focussing on studies of myometrial gene expression, Eidem et al. identified 15 584 
genes present in four or more studies. In our study, four TNF-induced genes were also present 585 
in the myometrial group identified by Eidem et al., including FOSB, NR4A1, LIF and PTGS2. 586 
Moreover, those genes reported to act as biomarkers of pre-term birth, including IL6 and TNF, 587 
were also represented in our work giving further validation of the TNF-induced gene 588 
expression data presented herein (Table II and Eidem et al., 2015). The meta-analysis described 589 
by Eidem et al., does not, however, consider changes in promoter occupancy of those gene 590 
targets, essentially because, other than our work, there are no data in the reproductive field 591 
describing such investigations. 592 
 593 
TNF-Induced Gene Expression  594 
In terms of NF-NB function, the NFKBIA gene, which encodes the INBD protein, was induced 595 
2.9 fold by TNF. As our positive control, this observation also validates the data presented 596 
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here. A second INB family member, NFKBIZ, which encodes the INB] protein, was induced 597 
5.2-fold in response to TNF. Significantly, other groups (Eto et al., 2003) have observed that 598 
INB] induction is not TNF-mediated. The differences in these observations may be accounted 599 
for through cell-type specific effects (macrophage or kidney versus myometrium) but it is 600 
noteworthy that one effector, TNF, can exert diametrically opposed effects on the same gene 601 
in different cell types, suggesting other nuclear-based factors are influencing the NF-NB-602 
mediated gene regulation process. Significantly, INB] is known to bind specifically to p50 603 
homodimers forming a robust ternary complex on the IL6 promoter activating expression of 604 
this gene (Trinh et al., 2008). Indeed, in our study TNF stimulation also caused a three-fold 605 
induction of IL-6 expression and we speculate this is mediated by p50 homodimer:INB] 606 
complex although further experimental analyses would be required to confirm this. TNFAIP3 607 
(also termed A20) was also up-regulated. This protein also plays a significant role in 608 
termination of the NF-NB signal by inhibiting NF-NB DNA binding (Perkins, 2012; Hayden 609 
and Ghosh 2012).  610 
 611 
Our study also identified various transcription factors that were significantly up-regulated in 612 
response to TNF, including members of the early growth response transcription factor family, 613 
Egr-1, -2, -3 and -4, as well as those of the AP1 family, namely ATF3, Fos, FosB, Jun, JunB. 614 
The Egr family are well-described zinc-finger containing proteins recognising the consensus 615 
sequence of 5-GCGG/TGGGCG-¶ (Christy and Nathans, 1989). The function of the Egr 616 
family in human myometrium is not clear but they have been shown to co-operate with the 617 
RelA subunit of NF-NB in embryonic kidney cells through an interaction between the RelA 618 
Rel Homology Domain and the zinc-finger region of Egr-1 (Chapman and Perkins, 2000), as 619 
well as competing for Sp1 sites in pro-inflammatory promoters such as PDGF-B (Khachigian 620 
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et al., 1996). Many of the promoters identified in our study were GC-rich and up-regulation of 621 
factors which readily bind to such regions offers a potential insight into the control of complex 622 
myometrial gene expression networks. 623 
 624 
Members of the AP1 transcription factor family, including Fos, FosB and Jun, bind to the 625 
FRQVHQVXV$3PRWLI¶-TGAG/CTCA-¶RU¶-TGACGTCA-¶6KDXOLDQDQG.DULQ626 
and have been shown to be differentially expressed in pregnant versus labouring rat 627 
myometrium.. Importantly, studies in rat myometrium have described the differential 628 
expression of members of this family, between pregnant and labouring states. The salient 629 
observation is that peak levels of Fos, FosB, Jun and JunB occur during active labour (Mitchell 630 
and Lye, 2002; Mohan et al., 2007); importantly, those observations are in keeping with our 631 
data from human cells. Moreover, since Fos/Jun are immediate early genes (Shaulian and 632 
Karin, 2002), they are likely regulators of more extensive transcriptional networks within the 633 
cell and it is therefore interesting to speculate that NF-NB dimers may orchestrate a hierarchy 634 
of transcriptional activity within the myometrial cell. Interestingly, NF-NB has also been shown 635 
to play a key regulatory role in JunB expression as part of the JunB-mediated induction of 636 
VEGF in response to hypoxia (Schmidt et al., 2007). It is well documented that uterine 637 
contractions during labour do induce local hypoxic regions (Bugg et al., 2006); whether such 638 
myometrial hypoxia initiates NF-NB-induced AP1 family expression remains unclear at present 639 
but induction of such factors may be how the uterus responds to such a hypoxic stress and 640 
utilises NF-NB to instigate this protective mechanism. 641 
 642 
Conclusions  643 
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In conclusion, our data demonstrate that RelA-containing dimers of NF-NB bind to numerous 644 
loci throughout the genome of PHM1-31 myometrial myocytes. For some promoters, this 645 
binding occurred in the presence of TNF as well as in unstimulated cells; this was mediated by 646 
different regions of the same promoter. Occupancy of other promoters was seen either only in 647 
unstimulated conditions or only after cells were stimulated by TNF. The consensus NB motif 648 
was identified 3,783 times in this study with over 100 different sequence instances potentially 649 
mediating NF-NB DNA binding. Of these NB motifs, 41%were found within intronic regions 650 
of the PHM1-31 cell chromatin. Of the 49 TNF-induced genes, 17 were shown to have 651 
promoters enriched by NF-NB in response to TNF. Interestingly, five genes with promoters 652 
occupied by NF-NB were repressed by TNF. Together, our data illustrate that NF-NB influences 653 
a wide range of regulatory gene networks within myometrial cells; we must decipher how these 654 
interactions govern myometrial function during pregnancy and labour if we are to begin to 655 
understand the syndrome of premature birth.   656 
 657 
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Figure Legends 1083 
Fig. 1: Schematic Representation of the Work-flow used to Generate Chromatin for this 1084 
Study.  1085 
 1086 
Fig 2: TNF Induces RelA NF-NB Activity in PHM1-31 Myometrial Cells. Immunostaining 1087 
was used to demonstrate TNF-mediated induction of RelA nuclear localisation in PHM1-31 1088 
myometrial cell lines (A; Panel-I, unstimulated; Panel-II, negative control; Panel-III, TNF-1089 
stimulated; scale bar = 100Pm). Nuclear extracts were prepared from PHM1-31 cells and 1090 
incubated with D-32P-ODEHOOHGROLJRQXFOHRWLGHKDUERXULQJWKH¶-HIV-LTR NB site. Three main 1091 
complexes were seen to form and, using supershift analyses, these were demonstrated to be 1092 
p50:RelA heterodimers, RelA homodimers and a lower non-specific complex. An increased 1093 
shift in RelA in TNF-treated cells illustrates TNF was inducing RelA NF-NB translocation to 1094 
the nucleus. Specificity of the experiment was confirmed by including an excess (100 ng) of 1095 
cold, HIV NB DNA (B). PHM1-31 cells were transfected with 200 ng of either 3x-NB-ConA-1096 
luc (NF-NB-responsive; C; Panel-I) or 'NB-ConA-luc (NF-NB unresponsive; C; Panel-II). 1097 
After 24 hours cells were stimulated with TNF (10 ng/ml) for one hour. Promoter activity was 1098 
quantified using a Berthold Sirius tube luminometer. All experiments were performed three 1099 
times in triplicate. Data were analysed using an unpaired, two-tailed t-test and results are 1100 
expressed as the mean r S.E.M. (error bars); p<0.05 was considered statistically significant. 1101 
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As expected, TNF induced NF-NB activity (C; Panel-I; p = 0.0001). No NF-NB activity was 1102 
observed in a control reporter lacking the NB site (C; Panel-II). Nuclear extracts were prepared 1103 
from PHM1-31 cells and subjected to immunoprecipitation with anti-RelA anti-serum. RelA 1104 
was recovered from both control and TNF-stimulated samples, illustrating the effectiveness of 1105 
the antiserum. Minimal non-specific binding was observed with IgG (D). RelA occupancy of 1106 
the INBD promoter was seen under basal conditions. In the presence of TNF, both RelA and 1107 
RNA Pol II were seen to be associated with the INBD promoter (E; Upper Panels). No RelA 1108 
occupancy of the control GDs promoter was observed, illustrating the specificity of the ChIP 1109 
assay (E; Lower Panels). 1110 
 1111 
)LJ&RPSDULVRQRI5HO$HQULFKHG&KURPDWLQ5HJLRQV. The Criteria-B dataset represents 1112 
all regions with a p-value <0.05. Within this, the Criteria-A dataset (red circle) represent those 1113 
regions where p<0.05 and the MAT score is >0; essentially, these regions are enriched over the 1114 
control in response to TNF. The Criteria-C dataset (blue circle) represents those regions where 1115 
p<0.05 and the MAT score is <0; essentially, these regions are enriched in the absence of TNF 1116 
stimulation (A). An illustrative heat map of chromosome 14 illustrating the loci of Criteria-A 1117 
regions (red bars) and Criteria-C regions (blue bars). Known transcripts from each strand are 1118 
represented by green blocks (B). 1119 
 1120 
Fig. 4: Genes within Criteria-A and Criteria-C Enriched Regions and Associated NB Motif 1121 
loci. Schematic representation of the loci of both Criteria-A (TNF-induced NF-NB enrichment) 1122 
and Criteria-C (unstimulated NF-NB enrichment) regions around selected genes including 1123 
COX-2 (A); Jun (B), IL6RN (C); KCNMB3 (D); CACNB3 (E) and KCNB1 (F). For COX-2 1124 
and Jun, NB motifs corresponding to the consensus were found in the TNF-induced RelA 1125 
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enriched regions (3A; 3B). With IL6RN and KCNMB3, both TNF-induced RelA enriched 1126 
regions and unstimulated RelA-enriched regions were observed. The former were not 1127 
associated with a consensus NB motif while the latter, unstimulated RelA-enriched, both 1128 
harboured consensus NB motifs (3C; 3D). Regions around CACNB3 and KCNB1 were not 1129 
enriched by RelA in the presence of TNF but were enriched by RelA in unstimulated cells, 1130 
possibly by the consensus NB motifs identified (3E; 3F). Arrows indicate the direction of 1131 
transcription, not actual transcription start sites. 1132 
 1133 
Fig. 5: Differential Enrichment of Regions around the NFKBIA (INBD) Gene Locus on 1134 
Chromosome 14. Low resolution schematic illustration of the INBD locus and surrounding 1135 
regions. In the absence of TNF, no enrichment around the INBD promoter is observed (A; blue 1136 
bars). In the presence of TNF, a number of regions around the promoter are enriched by the 1137 
anti-RelA antiserum (A; red bars). High resolution schematic illustration of the INBD 1138 
promoter illustrating TNF-induced regions enriched by the anti-RelA antiserum. One region 1139 
encompasses the INBD promoter and harbours the three reported NB motifs in that region. A 1140 
second intra-genic region, HQFRPSDVVLQJWKH¶ portion of exon 2 and all of exons 3 and 4, is 1141 
also enriched but no consensus NB motifs were identified therein (B). 1142 
 1143 
Fig. 6: Sequence Logo to Illustrate the Variability of NB Consensus Motif in Chromatin 1144 
from PHM1-31 Cells. 1145 
The consensus NB motifs presented in Table I were aligned in the open-access software 1146 
WebLogo 3. The probability of a given bases occurring at the proscribed position is illustrated. 1147 
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No difference in NB motif variability was noted between Criteria-A (TNF-induced) and 1148 
Criteria-C (unstimulated) datasets. 1149 
  1150 
Fig. 7: Comparison of TNF-Induced Differential Gene Expression. The Criteria-B1 dataset 1151 
represents 2,223 genes modified by TNF with a p-value <0.05. The Criteria-A1 and -B1 dataset 1152 
(red circle) represent those genes where p<0.05 and expression was increased 2-fold or more; 1153 
49 genes populated this intersection. The Criteria-C1 and -B1 (blue circle) represents those 1154 
genes regions where p<0.05 and expression was repressed by more than than 1.5 fold; 17 genes 1155 
populated this intersection. 1156 
 1157 
Fig. 8: GO Enrichment ± Biological Process and Validation of Expression Array Analyses 1158 
by qRT-PCR. Within the Biological Processes group, two functional groups of interest were 1159 
Intra-cellular Signal Transduction and Cell Surface Receptor Protein Signalling. This included 1160 
TNFAIP3 (Cytokine-mediated Signalling) and INBD (NIK/NF-NB Cascade) (A). qRT-PCR on 1161 
total RNA from PHM1-31 cells treated with TNF for one hour demonstrated that both INBD 1162 
and TNFAIP3 were expressed in response to TNF (B). A close agreement was seen for 1163 
induction of gene expression for INBD (4.43 for qRT-PCR; stippled bars vs. 2.94 on array; 1164 
diagonal stripes) while a slightly greater margin of difference was noted for TNFAIP3 1165 
expression (3.85 for qRT-PCR; stippled bars vs. 7.96 on array; diagonal stripes). 1166 
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